Uji klinis Epilepsi di Missouri
8 studi untuk Epilepsi mencari peserta di lokasi di Missouri.
Kota di Missouri
Teks studi resmi (Bahasa Inggris)
Diagnosing Epilepsy To EffeCT Change
- Washington University, St Louis
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07110337Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- Washington University, St Louis
Menerima pesertaStudi observasional
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07110454A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Saint Louis University Medical School, St Louis
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT05667142Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- St. Louis Children's Hospital, St Louis
Menerima pesertaStudi observasional
Hingga usia 26 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT05374824Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Washington University at St. Louis, St Louis
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT05135091Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
- Washington University -- St. Louis, St Louis
Menerima pesertaFase 2
1 Day – 6 Months · Semua jenis kelamin · Diperbarui 22 Jan 2026 · NCT05104983Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN)
- University of Missouri - Columbia, Columbia
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Hingga usia 99 · Semua jenis kelamin · Diperbarui 9 Jan 2026 · NCT07329257Amygdala Memory Enhancement
- Washington University School of Medicine, St Louis
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jul 2025 · NCT05065450Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.